Science

Homer-3 autoimmunity: Insights from a newly identified case

A new case of Homer-3 autoimmunity has been described, expanding the still limited body of knowledge about this rare autoimmune cerebellar disorder. The case was reported in the Journal of Neuroimmunology. What’s known so far To date, only 15 cases of Homer-3 autoantibody-associated disease have been described in the literature. The clinical phenotype in these […]

Science

Anti-ITPR1 autoimmunity – a case mimicking Alzheimer’s disease

Autoimmunity targeting inositol 1,4,5-triphosphate receptor type 1 (ITPR1) was identified as a potential cause of cognitive decline resembling Alzheimer’s disease in a retrospective case study. The findings were reported by a research group from Norway and Germany in collaboration with Euroimmun. Patient with acute deterioration The study describes a 58-year-old patient who presented with acute

Science

Robust performance of serological tests for coeliac disease in Tunisia

Serological tests for coeliac disease-specific antibodies showed exceptionally high sensitivity and specificity in a Tunisian cohort, underscoring their diagnostic utility. The recently published findings stem from a collaborative study between Euroimmun and various laboratories in Tunisia. Studying a unique population Coeliac disease is an autoimmune disorder triggered in genetically predisposed individuals by gluten ingestion. It

Science

Clarity on the floor: differentiating dermal-binding autoantibodies

A newly published international study has demonstrated the high sensitivity of the Euroimmun Dermal Binder Mosaic 1 for detecting antibodies against laminin β4, laminin 332 and collagen type VII. The prospective multicentre study represents the latest milestone in a long-standing research collaboration between Euroimmun and the University of Lübeck, Germany. Shedding light on anti-laminin β4

Science

On the trail of anti-laminin β4 autoantibodies

A collaboration driving discovery A long-standing research collaboration between Euroimmun and the University of Lübeck, Germany has led to major advances in understanding anti-p200 pemphigoid, a rare autoimmune skin blistering disease. Recent publications from the collaborative team have identified laminin subunit beta 4 (laminin β4) as a key autoantigen, demonstrated the pathogenic effects of anti-laminin

Scroll to Top